Table 1.
Stage 1 (n = 56) | Stage 2 (n = 77) | Stage 3 (n = 38) | Stage 4 (n = 90) | Total (n = 261) | |
---|---|---|---|---|---|
Age | |||||
Min/max | 18/37 | 16/44 | 17/38 | 15/48 | 15/48 |
Mean ± SD | 26.53 ± 6.03 | 27.25 ± 7.12 | 26.84 ± 5.89 | 27.13 ± 7.54 | 27 ± 6.82 |
Sex | |||||
Female (n, %) | 22 (40.7%) | 36 (46.1%) | 20 (52.6%) | 30 (33.3%) | 108 (41.2%) |
Male (n, %) | 34 (59.2%) | 41 (53.8%) | 18 (47.3%) | 60 (66.6%) | 153 (58.7%) |
Coverage | |||||
Min/max | 75/93 | 71/93 | 75/90 | 72/95 | 71/95 |
Mean ± SD | 82.7 ± 4.5 | 83.82 ± 4.2 | 82.6 ± 4.9 | 84.07 ± 6.8 | 83.6 ± 4.5 |
Centration | |||||
Min/max | 82/96 | 82/98 | 75/90 | 81/97 | 81/98 |
Mean ± SD | 91.3 ± 3.9 | 90.5 ± 3.4 | 90.9 ± 3.5 | 90.7 ± 3.8 | 90.7 ± 3.6 |